These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 17293853)
1. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853 [TBL] [Abstract][Full Text] [Related]
2. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Moumen A; Masterson P; O'Connor MJ; Jackson SP Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036 [TBL] [Abstract][Full Text] [Related]
3. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Le Cam L; Linares LK; Paul C; Julien E; Lacroix M; Hatchi E; Triboulet R; Bossis G; Shmueli A; Rodriguez MS; Coux O; Sardet C Cell; 2006 Nov; 127(4):775-88. PubMed ID: 17110336 [TBL] [Abstract][Full Text] [Related]
4. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239 [TBL] [Abstract][Full Text] [Related]
5. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells. Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664 [TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904 [TBL] [Abstract][Full Text] [Related]
7. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53. Heminger K; Markey M; Mpagi M; Berberich SJ Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469 [TBL] [Abstract][Full Text] [Related]
8. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Watts GS; Oshiro MM; Junk DJ; Wozniak RJ; Watterson S; Domann FE; Futscher BW Neoplasia; 2004; 6(3):187-94. PubMed ID: 15153330 [TBL] [Abstract][Full Text] [Related]
9. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Di Stefano V; Soddu S; Sacchi A; D'Orazi G Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882 [TBL] [Abstract][Full Text] [Related]
10. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014 [TBL] [Abstract][Full Text] [Related]
11. A new function for p53 ubiquitination. Hirano Y; Ronai Z Cell; 2006 Nov; 127(4):675-7. PubMed ID: 17110328 [TBL] [Abstract][Full Text] [Related]
12. Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities. Kass EM; Poyurovsky MV; Zhu Y; Prives C Cell Cycle; 2009 Feb; 8(3):430-7. PubMed ID: 19176998 [TBL] [Abstract][Full Text] [Related]
13. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation. Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042 [TBL] [Abstract][Full Text] [Related]
14. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation. Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825 [TBL] [Abstract][Full Text] [Related]
15. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994 [TBL] [Abstract][Full Text] [Related]
16. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Tang Y; Luo J; Zhang W; Gu W Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186 [TBL] [Abstract][Full Text] [Related]
17. To die or not to die: a HAT trick. Tyteca S; Legube G; Trouche D Mol Cell; 2006 Dec; 24(6):807-8. PubMed ID: 17189182 [TBL] [Abstract][Full Text] [Related]
18. A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage. Yan J; Menendez D; Yang XP; Resnick MA; Jetten AM J Biol Chem; 2009 Jul; 284(29):19280-9. PubMed ID: 19433585 [TBL] [Abstract][Full Text] [Related]
19. PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress. Mazzà D; Infante P; Colicchia V; Greco A; Alfonsi R; Siler M; Antonucci L; Po A; De Smaele E; Ferretti E; Capalbo C; Bellavia D; Canettieri G; Giannini G; Screpanti I; Gulino A; Di Marcotullio L Cell Death Differ; 2013 Dec; 20(12):1688-97. PubMed ID: 24013724 [TBL] [Abstract][Full Text] [Related]
20. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage. Magrini R; Russo D; Fronza G; Inga A; Menichini P J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]